DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM.
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
J Clin Oncol 2000; 18: 1888-1899
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.